Conjunctival modifications induced by medical and surgical therapies in patients with glaucoma

Current Opinion in Pharmacology

Volumn 13, Issue 1, 2013, Pages 56-64

  Mastropasqua, Leonardo ^a   Agnifili, Luca ^a   Mastropasqua, Rodolfo ^b   Fasanella, Vincenzo ^a  

^a UNIVERSITY OF CHIETI   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BENZALKONIUM CHLORIDE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BROMOCRIPTINE MESILATE; DIPIVEFRINE; FLUOROURACIL; HLA DR ANTIGEN; LATANOPROST; LEVOBUNOLOL; MIOTIC AGENT; MITOMYCIN; PILOCARPINE; PRESERVATIVE; TAFLUPROST; TIMOLOL; TRAVOPROST;

ALLERGIC CONJUNCTIVITIS; ANTIPROLIFERATIVE ACTIVITY; AQUEOUS HUMOR OUTFLOW; ARTICLE; CELL LOSS; CONJUNCTIVA DISEASE; CONJUNCTIVITIS; DISEASE CONTROL; DRUG FORMULATION; DRUG HYPERSENSITIVITY; EYE INJURY; EYE TOXICITY; FILTERING OPERATION; GLAUCOMA; GLAUCOMA DRAINAGE IMPLANT; GOBLET CELL; HUMAN; INTRAOCULAR HYPERTENSION; MUCOUS MEMBRANE PEMPHIGOID; NONHUMAN; PEROPERATIVE CARE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUALITY OF LIFE; SURGICAL APPROACH; TRABECULOTOMY; TREATMENT OUTCOME;

EID: 84871322189     PISSN: 14714892     EISSN: 14714973     Source Type: Journal    
DOI: 10.1016/j.coph.2012.10.002     Document Type: Review

References (52)

1. M.C. Leske, A. Heijl, M. Hussein, B. Bengtsson, L. Hyman, and E. Komaroff Early Manifest Glaucoma Trial Group: factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial Arch Ophthalmol 121 2003 48 56
2. P.R. Lichter, D.C. Musch, B.W. Gillespie, K.E. Guire, N.K. Janz, P.A. Wren, R.P. Mills CIGTS Study Group Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery Ophthalmology 108 2001 1943 1953
3. M. Ciancaglini, P. Carpineto, L. Agnifili, M. Nubile, V. Fasanella, M. Lanzini, R. Calienno, and L. Mastropasqua An in vivo confocal microscopy and impression cytology analysis of preserved and unpreserved levobunolol-induced conjunctival changes Eur J Ophthalmol 18 2008 400 407
4. A. Alm, I. Grierson, and M.B. Shields Side effects associated with prostaglandin analog therapy Surv Ophthalmol 53 Suppl 1 2008 S93 S105
5. R. Arita, K. Itoh, S. Maeda, K. Maeda, A. Furuta, A. Tomidokoro, M. Aihara, and S. Amano Effects of long-term topical anti-glaucoma medications on meibomian glands Graefes Arch Clin Exp Ophthalmol 250 2012 1181 1185
6. D.C. Broadway, I. Grierson, C. O'Brien, and R.A. Hitchings Adverse effects of topical antiglaucoma medication. II. The outcome of filtration surgery Arch Ophthalmol 112 1994 1446 1454
7. J.P. Nordmann, N. Auzanneau, S. Ricard, and G. Berdeaux Vision-related quality of life and topical glaucoma treatment side-effects Health Qual Life Outcomes 10 2003 75
8. R.M. Feldman, and R.R. Tabet Needle revision of filtering blebs J Glaucoma 17 2008 594 600
9. D.Y. Yu, W.H. Morgan, X. Sun, E.N. Su, S.J. Cringle, P.K. Yu, P. House, W. Guo, and X. Yu The critical role of the conjunctiva in glaucoma filtration surgery Prog Retin Eye Res 28 2009 303 328
10. P. Khaw, F. Grehn, G. Holló, B. Overton, R. Wilson, R. Vogel, Z. Smith CAT-152 0102 Trabeculectomy Study Group A phase III study of subconjunctival human anti-transforming growth factor beta(2) monoclonal antibody (CAT-152) to prevent scarring after first-time trabeculectomy Ophthalmology 114 2007 1822 1830
11. M.C. Grieshaber, A. Pienaar, J. Olivier, and R. Stegmann Canaloplasty for primary open-angle glaucoma: long-term outcome Br J Ophthalmol 94 2010 1478 1482
12. L. Agnifili, C. Costagliola, M. Figus, G. Iezzi, A. Piattelli, P. Carpineto, R. Mastropasqua, M. Nardi, and L. Mastropasqua Histological findings of failed gold micro shunts in primary open angle glaucoma Graefes Arch Clin Exp Ophthalmol 250 2012 143 149
13. C.K. Bahler, C.R. Hann, T. Fjield, D. Haffner, H. Heitzmann, and M.P. Fautsch Second generation trabecular meshwork bypass stent (iStent inject) increases outflow facility in cultured human anterior segments Am J Ophthalmol 153 2012 1206 1213
14. M. Ciancaglini, P. Carpineto, L. Agnifili, M. Nubile, V. Fasanella, P.A. Mattei, and L. Mastropasqua Conjunctival characteristics in primary open angle glaucoma and modifications induced by trabeculectomy with mitomycin C: an in vivo confocal microscopy study Br J Ophthalmol 93 2009 1204 1209
15. L. Mastropasqua, L. Agnifili, M. Ciancaglini, M. Nubile, P. Carpineto, V. Fasanella, M. Figus, S. Lazzeri, and M. Nardi In vivo analysis of conjunctiva in gold micro shunt implantation for glaucoma Br J Ophthalmol 94 2010 1592 1596
16. L. Mastropasqua, L. Agnifili, M.L. Salvetat, M. Ciancaglini, V. Fasanella, M. Nubile, R. Mastropasqua, M. Zeppieri, and P. Brusini In vivo analysis of conjunctiva in canaloplasty for glaucoma Br J Ophthalmol 96 2012 634 639
17. C. Baudouin Detrimental effect of preservatives in eyedrops: implications for the treatment of glaucoma Acta Ophthalmol 86 2008 716 726
18. C. Baudouin, A. Labbè, H. Liang, A. Pauly, and F. Brignole-Baudouin Preservatives in eye drops: the good, the bad and the ugly Prog Ret Eye Res 29 2010 312 334
19. M. De Saint Jean, F. Brignole, A.F. Bringuier, A. Bauchet, G. Feldmann, and C. Baudouin Effects of benzalkonium chloride on growth and survival of Chang conjunctival cells Invest Ophthalmol Vis Sci 40 1999 619 630
20. R. Noecker, and K.V. Miller Benzalkonium chloride in glaucoma medications Ocul Surf 9 2011 159 162
21. E. Champeau, and H. Edelhauser Effect of ophthalmic preservatives on the ocular surface: conjunctival and corneal uptake and distribution of benzalkonium chloride and chlorhexidine digluconate F. Holly, The Preocular Tear Film 1986 Dry Eye Institute, Inc Lubbock, TX
22. M.H. Friedlaender, D. Breshears, B. Amoozgar, H. Sheardown, and M. Senchyna The dilution of benzalkonium chloride (BAK) in the tear film Adv Ther 23 2006 835 841
23. C. Baudouin, H. Liang, P. Hamard, L. Riancho, C. Creuzot-Garcher, J.M. Warnet, and F. Brignole-Baudouin The ocular surface of glaucoma patients treated over the long term expresses inflammatory markers related to both T-helper 1 and T-helper 2 pathways Ophthalmology 115 2008 109 115
24. A. Pauly, F. Brignole-Baudouin, A. Labbé, H. Liang, J.M. Warnet, and C. Baudouin New tools for the evaluation of toxic ocular surface changes in the rat Invest Ophthalmol Vis Sci 48 2007 5473 5483
25. R.J. Noecker, L.A. Herrygers, and R. Anwaruddin Corneal and conjunctival changes caused by commonly used glaucoma medications Cornea 23 2004 490 496
26. M.Y. Kahook, and R.J. Noecker Comparison of corneal and conjunctival changes after dosing of travoprost preserved with sofZia, latanoprost with 0.02% benzalkonium chloride, and preservative-free artificial tears Cornea 27 2008 339 343
27. D.A. Ammar, R.J. Noecker, and M.Y. Kahook Effects of benzalkonium chloride preserved, polyquad-preserved, and sofZia-preserved topical glaucoma medications on human ocular epithelial cells Adv Ther 27 2010 837 845
28. C. Baudouin, P. Hamard, H. Liang, C. Creuzot-Garcher, L. Bensoussan, and F. Brignole Conjunctival epithelial cell expression of interleukins and inflammatory markers in glaucoma patients treated over the long term Ophthalmology 111 2004 2186 2192
29. E. Guglielminetti, S. Barabino, M. Monaco, S. Mantero, and M. Rolando HLA-DR expression in conjunctival cells after latanoprost J Ocul Pharmacol Ther 18 2002 1 9
30. M.Y. Kahook, and R. Noecker Quantitative analysis of conjunctival goblet cells after chronic application of topical drops Adv Ther 25 2008 743 751
31. H. Liang, C. Baudouin, A. Pauly, and F. Brignole-Baudouin Conjunctival and corneal reactions in rabbits following short- and repeated exposure to preservative-free tafluprost, commercially available latanoprost and 0.02% benzalkonium chloride Br J Ophthalmol 92 2008 1275 1282
32. P.J. Pisella, C. Debbasch, P. Hamard, C. Creuzot-Garcher, P. Rat, F. Brignole, and C. Baudouin Conjunctival proinflammatory and proapoptotic effects of latanoprost and preserved and unpreserved timolol: an ex vivo and in vitro study Invest Ophthalmol Vis Sci 45 2004 1360 1368
33. C.S. Tressler, R.M.D. Beatty, and M.A. Lemp Preservative use in topical glaucoma medications Ocul Surf 9 2011 140 158
34. R. Nuzzi, A. Vercelli, C. Finazzo, and C. Cracco Conjunctiva and subconjunctival tissue in primary open-angle glaucoma after long-term topical treatment: an immunohistochemical and ultrastructural study Graefes Arch Clin Exp Ophthalmol 233 1995 154 162
35. S. Hong, C.S. Lee, K.Y. Seo, G.J. Seong, and Y.J. Hong Effects of topical antiglaucoma application on conjunctival impression cytology specimens Am J Ophthalmol 142 2006 185 186
36. M. Francoz, I. Karamoko, C. Baudouin, and A. Labbè Ocular surface epithelial thickness evaluation with Spectral-Domain Optical Coherence Tomography Invest Ophthalmol Vis Sci 52 2011 9116 9123
37. A.S. Doǧan, M. Orhan, F. Söylemezoǧlu, M. Irkeç, and B. Bozkurt Effects of topical antiglaucoma drugs on apoptosis rates of conjunctival epithelial cells in glaucoma patients Clin Exp Ophthalmol 32 2004 62 66
38. M.B. Sherwood, I. Grierson, L. Millar, and R.A. Hitchings Long-term morphologic effects of antiglaucoma drugs on the conjunctiva and Tenon's capsule in glaucomatous patients Ophthalmology 96 1989 327 335
39. R.A. Lewis, G.J. Katz, M.J. Weiss, T.A. Landry, J.E. Dickerson, J.E. James, S.Y. Hua, E.K. Sullivan, D.B. Montgomery, and D.T. Wells Travoprost 0.004% with and without benzalkonium chloride: a comparison of safety and efficacy J Glaucoma 16 2007 98 103
40. M. Rolando, V. Brezzo, G. Giordano, P. Campagna, S. Burlando, and G. Calabria The effect of different benzalkonium chloride concentrations on human normal ocular surface O. Van Bijsterveld, M. Lemp, D. Spinelli, The Lacrimal System 2004 Kugler and Ghedini Publications Amsterdam/Berkely/Milano
41. H.H. Russ, V.P. Costa, F.M. Ferreira, S.R. Valgas, M.A. Correa Neto, E.L. Strobel, and J.H. Truppel Conjunctival changes induced by prostaglandin analogues and timolol maleate: a histomorphometric study Arq Bras Oftalmol 70 2007 910 916
42. C. Baudouin, C. Garcher, N. Haouat, A. Bron, and P. Gastaud Expression of inflammatory membrane markers by conjunctival cells in chronically treated patients with glaucoma Ophthalmology 101 1994 454 460
43. C. Baudouin, P.J. Pisella, K. Fillacier, M. Goldschild, F. Becquet, M. De Saint Jean, and A. Béchetoille Ocular surface inflammatory changes induced by topical antiglaucoma drugs: human and animal studies Ophthalmology 106 1999 556 563
44. E.V. Nguyen, D. Azar, D. Papalkar, and P. McCluskey Brimonidine-induced anterior uveitis and conjunctivitis clinical and histologic features J Glaucoma 17 2008 40 42
45. B.C. Leal, F.A. Medeiros, F.W. Medeiros, R.M. Santo, and R. Susanna Jr. Conjunctival hyperemia associated with bimatoprost use: a histopathologic study Am J Ophthalmol 138 2004 310 313
46. S.E. Skalicky, I. Goldberg, and P. McCluskey Ocular surface disease and quality of life in patients with glaucoma Am J Ophthalmol 153 2012 1 9
47. S.Y.-W. Liang, G.A. Lee, and K. Whitehead Histopathology of a functioning mitomycin-C trabeculectomy Clin and Exp Ophthalmol 37 2009 316 319
48. N. Amar, A. Labbè, P. Hamard, B. Dupas, and C. Baudouin Filtering blebs and aqueous pathway. An immunocytological and in vivo confocal microscopy Ophthalmology 115 2008 1154 1161
49. ® or mitomycin-C Mol Vis 18 2012 714 719
50. R.C. Tripathi, N.S.C. Borisuth, and B.J. Tripathi Growth factors in the aqueous humor and their therapeutic implications in glaucoma and anterior segment disorders of the human eye Drug Dev Res 22 2004 1 23
51. M. Ciancaglini, P. Carpineto, L. Agnifili, M. Nubile, V. Fasanella, and L. Mastropasqua Conjunctival modifications in ocular hypertension and primary open angle glaucoma: an in vivo confocal microscopy study Invest Ophthalmol Vis Sci 49 2008 3042 3048
52. L. Agnifili, P. Carpineto, V. Fasanella, R. Mastropasqua, A. Zappacosta, S. Di Staso, C. Costagliola, and L. Mastropasqua Conjunctival findings in hyperbaric and low-tension glaucoma: an in vivo confocal microscopy study Acta Ophthalmol 2011 10.1111/j.1755-3768.2011.02255.x [epub ahead of print]